These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1400074)

  • 1. Considerations for using lower doses of warfarin.
    Bern MM
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1105-14. PubMed ID: 1400074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing DVT following total knee replacement: a review of recent clinical trials.
    Fitzgerald RH
    Orthopedics; 1995 Jul; 18 Suppl():10-1. PubMed ID: 7479418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.
    Poller L; McKernan A; Thomson JM; Elstein M; Hirsch PJ; Jones JB
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1309-12. PubMed ID: 3120989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts of warfarin therapy.
    Peterson CE; Kwaan HC
    Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consortium data: comparative efficacy of low molecular weight heparin and warfarin following total hip replacement.
    Colwell CW
    Orthopedics; 1995 Jul; 18 Suppl():21-3. PubMed ID: 7479422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of prophylactic preoperative administration of low-dose warfarin in cemented total knee prostheses].
    Laflamme GY; Laflamme GH; Paiement GD; Beaumont P
    Ann Chir; 1994; 48(8):717-22. PubMed ID: 7872620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients.
    Veerabagu MP; Tuttle-Newhall J; Maliakkal R; Champagne C; Mascioli EA
    Nutrition; 1995; 11(2):142-4. PubMed ID: 7647477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis.
    Perret-Guillaume C; Wahl DG
    Thromb Haemost; 2004 Feb; 91(2):394-402. PubMed ID: 14961170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement.
    Francis CW; Pellegrini VD; Leibert KM; Totterman S; Azodo MV; Harris CM; Cox C; Marder VJ
    Thromb Haemost; 1996 May; 75(5):706-11. PubMed ID: 8725709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.
    Douketis JD; Crowther MA; Cherian SS
    Can J Cardiol; 2000 Mar; 16(3):326-30. PubMed ID: 10744795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring for oral anticoagulant therapy].
    Nakagawa K; Nakahara Y; Tsuji H
    Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis and treatment of deep vein thrombosis in general surgery.
    Gutt CN; Oniu T; Wolkener F; Mehrabi A; Mistry S; Büchler MW
    Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ximelagatran: a new oral anticoagulant.
    Hrebickova L; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethrombosis--warfarin or low-dose heparin?
    Wessler S; Gitel SN
    N Engl J Med; 1979 Oct; 301(16):889-91. PubMed ID: 384252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.